Pilot study on glycaemic variability in type 2 diabetes mellitus patients with basal insulin and fixed combo oral antidiabetic treatment.
Phase of Trial: Phase IV
Latest Information Update: 25 Aug 2011
At a glance
- Drugs Antihyperglycaemics; Insulin; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Sanofi
- 31 Aug 2018 Biomarkers information updated
- 05 Aug 2008 Primary endpoint identified as self monitoring blood glucose values as reported by ClinicalTrials.gov.
- 05 Aug 2008 The expected completion date for this trial is now 1 May 2006 as reported by Clinicaltrials.gov.